tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INMB Stock Latest News

Inmune Bio Secures Favorable Patentability Opinion for CORDStrom™
Company AnnouncementsInmune Bio Secures Favorable Patentability Opinion for CORDStrom™
14d ago
8K
INMB
INmune Bio receives favorable patentability opinion for CORDStrom platform
PremiumThe Fly
INmune Bio receives favorable patentability opinion for CORDStrom platform
15d ago
INMB
INmune Bio partners with Cell, Gene Therapy Catapult to scale up CORDStrom
PremiumThe Fly
INmune Bio partners with Cell, Gene Therapy Catapult to scale up CORDStrom
17d ago
INMB
Inmune Bio Presents Alzheimer’s Trial Data at Conference
PremiumCompany Announcements
Inmune Bio Presents Alzheimer’s Trial Data at Conference
22d ago
8K
INMB
Inmune Bio’s Promising Alzheimer’s Treatment and Growth Potential: A Buy Recommendation by Thomas Shrader
PremiumRatings
Inmune Bio’s Promising Alzheimer’s Treatment and Growth Potential: A Buy Recommendation by Thomas Shrader
24d ago
INMB
Inmune Bio’s Promising Future: Buy Rating Backed by Key Data Releases and Innovative Approaches
PremiumRatingsInmune Bio’s Promising Future: Buy Rating Backed by Key Data Releases and Innovative Approaches
30d ago
INMB
INmune Bio presents baseline demographics of participants in MINDFuL study
Premium
The Fly
INmune Bio presents baseline demographics of participants in MINDFuL study
30d ago
INMB
INmune Bio’s Earnings Call: Key Insights and Future Prospects
Premium
Company Announcements
INmune Bio’s Earnings Call: Key Insights and Future Prospects
1M ago
INMB
INmune Bio Reports 2024 Financial Results and Clinical Progress
PremiumCompany Announcements
INmune Bio Reports 2024 Financial Results and Clinical Progress
1M ago
INMB
INMB Earnings this Week: How Will it Perform?
PremiumPre-Earnings
INMB Earnings this Week: How Will it Perform?
1M ago
INMB
INmune Bio Reports Promising Phase I/II Trial Results
PremiumCompany Announcements
INmune Bio Reports Promising Phase I/II Trial Results
2M ago
8K
INMB
INmune Bio price target raised to $30 from $22 at Maxim
PremiumThe Fly
INmune Bio price target raised to $30 from $22 at Maxim
3M ago
INMB
INmune Bio opens Phase II in high dose cohort of INKmune trial
PremiumThe FlyINmune Bio opens Phase II in high dose cohort of INKmune trial
3M ago
INMB
Inmune Bio’s Strategic Advancements and Promising Clinical Trials Justify Buy Rating
Premium
Ratings
Inmune Bio’s Strategic Advancements and Promising Clinical Trials Justify Buy Rating
3M ago
INMB
INmune Bio price target raised to $23 from $22 at Scotiabank
Premium
The Fly
INmune Bio price target raised to $23 from $22 at Scotiabank
3M ago
INMB
Inmune Bio Secures License Agreement for CORDStrom Data
PremiumCompany Announcements
Inmune Bio Secures License Agreement for CORDStrom Data
3M ago
8K
INMB
Inmune Bio Completes Phase 2 Trial for CORDStrom
PremiumCompany Announcements
Inmune Bio Completes Phase 2 Trial for CORDStrom
3M ago
8K
INMB
INmune Bio announces plans to submit FDA BLA for CORDStrom
PremiumThe Fly
INmune Bio announces plans to submit FDA BLA for CORDStrom
3M ago
INMB
INmune Bio expands INKmune trial in prostate cancer to veterans
PremiumThe Fly
INmune Bio expands INKmune trial in prostate cancer to veterans
3M ago
INMB
INmune Bio initiated with a Buy at Rodman & Renshaw
PremiumThe FlyINmune Bio initiated with a Buy at Rodman & Renshaw
3M ago
INMB
Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks
Premium
Stock Analysis & Ideas
Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks
4M ago
BDTX
INMB
INmune Bio treatment of epidermolysis bullosa receives FDA orphan designation
Premium
The Fly
INmune Bio treatment of epidermolysis bullosa receives FDA orphan designation
4M ago
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >